Pill versions of GLP-1 drugs arrive in 2026, but analysts say Eli Lilly’s lead in obesity and diabetes treatment should hold ...

The Food and Drug Administration has approved the first GLP-1 pill for weight loss and maintenance. Drugmaker Novo Nordisk ...

The Wegovy pill is expected to hit the market in January, joining injectable GLP-1 drugs that have transformed obesity treatment. One form you swallow, the other you inject. What else is different?

The FDA has approved the first GLP-1 pill for weight loss and it's expected in pharmacies in the coming weeks. Dr. Holly ...

The Food and Drug Administration has approved Novo Nordisk’s once-daily Wegovy pill, the first oral GLP-1 medicine for ...

Novo Nordisk said it plans to start selling the new pill in the U.S. soon after the new year, with a cash price of $149 a ...

There’s “quite big news” around weight loss medications circulating right now, says Wajahat Mehal, MD, director of Yale ...

In the studies the company submitted to the FDA, people who took the daily Wegovy pill lost about the same amount of ...

The FDA has approved the first-ever Wegovy pill for weight loss, with the oral GLP-1 offering a 16.6% average weight ...

Novo Nordisk plans to quickly launch the pill form of Wegovy but is expected to soon face competition from Eli Lilly.

The changing market is forcing the drugmakers to hire people with more consumer-focused expertise, strike more deals with ...

Novo Nordisk plans to sell its newly approved obesity pill directly to patients at a lower price than a competing medicine ...